Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

Thomas Anthony D'Amico

Gary Hock Distinguished Professor of Surgery
Surgery, Cardiovascular and Thoracic Surgery
Box 3496 Med Ctr, Durham, NC 27710
Duke South - 3589 White Zone, Durham, NC 27710

Overview


Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations


Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Current Appointments & Affiliations


Gary Hock Distinguished Professor of Surgery · 2013 - Present Surgery, Cardiovascular and Thoracic Surgery, Surgery
Professor of Surgery · 2007 - Present Surgery, Cardiovascular and Thoracic Surgery, Surgery
Member of the Duke Cancer Institute · 2012 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non-small cell lung cancer.

Journal Article J Thorac Cardiovasc Surg · May 2, 2026 OBJECTIVE: Multimodal therapy is recommended for the optimal treatment of N2 positive non-small cell lung cancer (NSCLC). Recent advancements in the use of immune checkpoint inhibitors and targeted therapy have dramatically changed the landscape of treatme ... Full text Link to item Cite

Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trial.

Journal Article Cancer · December 15, 2025 INTRODUCTION: Esophagogastric cancers are common and carry a poor prognosis. A standard option for locally advanced disease has been neoadjuvant chemoradiation (CRT) followed by surgical resection. The primary goal of this study was to investigate whether ... Full text Link to item Cite
View All Publications

Recent Grants


Clinical Oncology Research Career Development Program

ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015

Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers

ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2007

Genetics, Inflammation & Post-op Cognitive Dysfunction

ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 2006

View All Grants

Education


Columbia University · 1987 M.D.